PAX Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Buy
1,103
+126
+13% +$129K 0.2% 83
2026
Q1
$899K Buy
977
+52
+6% +$52.7K 0.15% 93
2025
Q4
$994K Buy
925
+63
+7% +$60.2K 0.17% 91
2025
Q3
$658K Buy
862
+58
+7% +$43.2K 0.12% 118
2025
Q2
$627K Sell
804
-293
-27% -$228K 0.12% 127
2025
Q1
$906K Buy
1,097
+77
+8% +$64.1K 0.16% 110
2024
Q4
$787K Buy
1,020
+167
+20% +$138K 0.14% 127
2024
Q3
$756K Buy
853
+136
+19% +$122K 0.14% 133
2024
Q2
$649K Buy
717
+259
+57% +$207K 0.13% 144
2024
Q1
$356K Buy
458
+15
+3% +$10.7K 0.07% 190
2023
Q4
$326K Buy
+443
New +$259K 0.07% 189
2022
Q2
Sell
-951
Closed -$272K 188
2022
Q1
$272K Sell
951
-485
-34% -$125K 0.06% 177
2021
Q4
$397K Buy
1,436
+30
+2% +$7.61K 0.09% 147
2021
Q3
$325K Buy
1,406
+486
+53% +$120K 0.08% 151
2021
Q2
$211K Buy
+920
New +$185K 0.05% 161

Other funds holding LLY

PAX Financial Group's LLY Position: Q2 2026 in Review

PAX Financial Group increased its Eli Lilly (LLY) stake by 13% in Q2 2026, buying an estimated $129K and bringing the position to 1,103 shares worth $1.32M. The position accounts for 0.2% of the portfolio, ranked #83.

PAX Financial Group first reported a position in LLY in Q2 2021 and has held it in 15 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • PAX Financial Group held 1,103 shares of Eli Lilly worth $1.32M as of Q2 2026.
  • PAX Financial Group bought 126 Eli Lilly shares in Q2 2026, an estimated $129K.
  • Eli Lilly made up 0.2% of PAX Financial Group's portfolio in Q2 2026, its #83 holding.
  • PAX Financial Group first reported a position in Eli Lilly in Q2 2021 and has held it in 15 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on PAX Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.